With respect to the guidelines on the management of diabetes;Les recommandations SFC/ALFEDIAM

Archives des Maladies du Coeur et des Vaisseaux

Volumn 97, Issue 3, 2004, Pages 185-186

  Danchin, N ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL ANTIDIABETIC AGENT;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETES CONTROL; DIABETES MELLITUS; DIAGNOSTIC TEST; EDITORIAL; FRANCE; HEART MUSCLE ISCHEMIA; HUMAN; LIFESTYLE; PRACTICE GUIDELINE; RESTENOSIS;

CARDIOLOGY; DIABETES COMPLICATIONS; DIABETES MELLITUS; HEART DISEASES; HUMANS; PRACTICE GUIDELINES; SOCIETIES, MEDICAL;

EID: 1842430445     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (6)

1. Otel I, Ledru F, Danchin N. Ischemic heart disease in type 2 diabetes. Metabolism 2003; 52 (suppl 1): 6-12
2. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-34
3. Henry P, Makowski S, Richard P et al. Increased incidence of moderate stenosis among patients with diabetes substrate for myocardial infarction? Am Heart J 1997; 134: 1037-43.
4. Ledru F, Ducimetière P, Battaglia S et al. New diagnostic criteria for diabetes and coronary artery-disease: insights from an angiographic study. J Am Coll Cardiol 2001; 37: 1543-50.
5. Puel J, Valensi P, Vanzetto G et al. Identification de l'ischémie myocardique chez le diabétique. In press.
6. Charbonnel B, Bouhanick B, Le Feuvre C et al. Recommandations SFC/ALFEDIAM sur la prise en charge du patient diabétique vu par le cardiologue. Arch Mol Cœur 2004; 97: 229-49.